Carlos Oliveira

4 Patents

• US122303982025

  Predictive Test for Patient Benefit from Antibody Drug Blocking Ligand Activation of the T-cell Programmed Cell Death 1 (PD-1) Checkpoint Protein and Classifier Development Methods

  BIODESIX, Inc.

  0 cites
• US120945872024

  Apparatus and Method for Identification of Primary Immune Resistance in Cancer Patients

  Biodesix, Inc.

  0 cites
• US119431262024

  Using a Traffic Monitoring Service to Detect Traffic Pattern Shifts

  AT&T Intellectual Property I, L.P.

  0 cites
• US117105392023

  Predictive Test for Melanoma Patient Benefit from Interleukin-2 (IL2) Therapy

  BIODESIX, Inc.

  0 cites